Cargando…

Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder

BACKGROUND: Increases in pro-inflammatory cytokines are found in the brain and blood of people with schizophrenia. However, increased cytokines are not evident in all people with schizophrenia, but are found in a subset. The cytokine changes that best define this subset, termed the “elevated inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boerrigter, Danny, Weickert, Thomas W., Lenroot, Rhoshel, O’Donnell, Maryanne, Galletly, Cherrie, Liu, Dennis, Burgess, Martin, Cadiz, Roxanne, Jacomb, Isabella, Catts, Vibeke S., Fillman, Stu G., Weickert, Cynthia Shannon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604300/ https://www.ncbi.nlm.nih.gov/pubmed/28923068 http://dx.doi.org/10.1186/s12974-017-0962-y

Ejemplares similares

C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
por: Jacomb, Isabella, et al.
Publicado: (2018)

Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2019)

Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation
por: Cai, Helen Q., et al.
Publicado: (2018)

M62. PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS
por: Weickert, Thomas, et al.
Publicado: (2020)

Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume
por: Fillman, S G, et al.
Publicado: (2016)

Speaker 1: Vibeke Catts, Australia
por: Catts, Vibeke S., et al.
Publicado: (2016)

O1.5. ICAM-1 IS INCREASED IN BRAIN AND PERIPHERAL LEVELS OF SOLUBLE ICAM-1 IS RELATED TO COGNITIVE DEFICITS IN SCHIZOPHRENIA
por: Weickert, Thomas, et al.
Publicado: (2018)

Brain antibodies in the cortex and blood of people with schizophrenia and controls
por: Glass, L J, et al.
Publicado: (2017)

Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia
por: Vercammen, Ans, et al.
Publicado: (2013)

Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2015)

Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases
por: Murphy, Caitlin E., et al.
Publicado: (2022)

Increases in [(3)H]Muscimol and [(3)H]Flumazenil Binding in the Dorsolateral Prefrontal Cortex in Schizophrenia Are Linked to α4 and γ2S mRNA Levels Respectively
por: Verdurand, Mathieu, et al.
Publicado: (2013)

The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes
por: Wells, Ruth, et al.
Publicado: (2015)

Rethinking schizophrenia in the context of normal neurodevelopment
por: Catts, Vibeke S., et al.
Publicado: (2013)

Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness
por: Sinclair, Duncan, et al.
Publicado: (2013)

Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
por: Catts, Vibeke Sørensen, et al.
Publicado: (2012)

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
por: Weickert, T W, et al.
Publicado: (2015)

Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development
por: Lambe, Evelyn K., et al.
Publicado: (2011)

Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study
por: Joshi, Dipesh, et al.
Publicado: (2015)

Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia
por: Catts, Vibeke Sørensen, et al.
Publicado: (2015)

Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia
por: Skilleter, A. J., et al.
Publicado: (2015)

Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia
por: Morris, R W, et al.
Publicado: (2012)

O11.2. ELEVATION OF MACROPHAGE-RELATED TRANSCRIPTS IN THE MIDBRAIN IN SCHIZOPHRENIA
por: Purves-Tyson, Tertia, et al.
Publicado: (2020)

Common polymorphisms in dopamine-related genes combine to produce a ‘schizophrenia-like' prefrontal hypoactivity
por: Vercammen, A, et al.
Publicado: (2014)

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
por: Mohamed Saini, Suriati, et al.
Publicado: (2023)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

M99. INVESTIGATING THE BEST PREDICTIVE CLINICAL FEATURES OF ANTI-N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS IN THE 2010 AUSTRALIAN NATIONAL SURVEY OF HIGH IMPACT PSYCHOSIS (SHIP) COHORT
por: Rossell, Susan, et al.
Publicado: (2020)

Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
por: Fillman, S G, et al.
Publicado: (2014)

Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers
por: Mathews, Kathryn J., et al.
Publicado: (2017)

Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia
por: Ji, E, et al.
Publicado: (2016)

Peripheral inflammatory biomarkers define biotypes of bipolar depression
por: Lee, Yena, et al.
Publicado: (2021)

Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls
por: Fullerton, Janice M., et al.
Publicado: (2018)

Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation
por: Zhang, Y, et al.
Publicado: (2016)

Heterogeneity within Autism Spectrum Disorders: What have We Learned from Neuroimaging Studies?
por: Lenroot, Rhoshel K., et al.
Publicado: (2013)

A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder
por: O’Reilly, Ken, et al.
Publicado: (2019)

Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept
por: Hamshere, M. L., et al.
Publicado: (2009)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
por: Weickert, Thomas W., et al.
Publicado: (2017)

The neuropsychiatric effects of vitamin C deficiency: a systematic review
por: Plevin, David, et al.
Publicado: (2020)

Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders
por: Hagihara, Hideo, et al.
Publicado: (2018)

SCHIZOAFFECTIVE DISORDER : CONSISTENCY OF DIAGNOSIS
por: Shrivastava, Amresh, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_dakrtho6qo3stfthq0pnmfsr68